ALS (motor neurone disease): open trials in Netherlands

9 open trials have a site in Netherlands. Registry data; only the trial team decides who can take part.

NCT07287397
Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
Trial Treatment · Phase 1/2 · Vector Y Therapeutics
Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-10-30
NCT07322003
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Trial Treatment · Phase 3 · Prilenia
UMC Utrecht, Utrecht
Registry updated 2026-10-27
NCT07674667
FUNCtion ALS: Aiming to Restore UNC13A Function in People Living With ALS
Trial Treatment · Phase 1/2 · Trace Neuroscience, Inc.
University Medical Center Utrecht, Utrecht
Registry updated 2026-10-14
2025-523111-11-00
A Randomized Phase 1 / 2 Trial Aiming to Restore UNC13A Function in People living with ALS: FUNCtion ALS
Trial Treatment · Phase 1/2 · Trace Neuroscience Inc.
Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-09-22
NCT07023835
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
Trial Treatment · Phase 2 · Zydus Therapeutics Inc.
Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-09-01
2025-523872-22-00
Research into the safety of a new agent (NRG5051) in healthy adults and patients with Parkinson's disease or ALS
Trial Treatment · Phase 1 · Nrg Therapeutics Limited
Centre for Human Drug Research, Leiden
Registry updated 2026-07-09
2025-524002-16-00
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS (PREVAiLS)
Trial Treatment · Phase 3 · Ferrer Internacional S.A.
Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-05-14
NCT06782724
Psilocybin Therapy for Psychological Distress in Palliative Patients
Trial Treatment · Phase 2 · University Medical Center Groningen
Universitair Medisch Centrum Groningen, Groningen
Registry updated 2026-05-08
NCT07100119
A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
Trial Treatment · Phase 1 · Eli Lilly and Company
Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-03-06

All ALS (motor neurone disease) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error